Open AccessWarfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
Author(s) -
Robert G. Hart,
Lesly A. Pearce,
Richard Asinger,
Charles A. Herzog
Publication year - 2011
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.02400311
Subject(s) - medicine , warfarin , atrial fibrillation , aspirin , stroke (engine) , kidney disease , hazard ratio , cardiology , randomized controlled trial , confidence interval , mechanical engineering , engineering
The efficacy of adjusted-dose warfarin for prevention of stroke in atrial fibrillation patients with stage 3 chronic kidney disease (CKD) is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom